Price T Rowe Associates Inc Re Shape Lifesciences Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.32 - $15.6 $43,136 - $2.1 Million
-134,800 Reduced 78.88%
36,100 $11,000
Q4 2021

Feb 14, 2022
BUY
$1.64 - $3.13 $57,728 - $110,176
35,200 Added 25.94%
170,900 $280,000
Q3 2021

Nov 15, 2021
BUY
$2.67 - $5.09 $362,319 - $690,713
135,700 New
135,700 $391,000

About ReShape Lifesciences Inc.

RSLS Quotes by TradingView
  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $130M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email